HIF1A and type 1 diabetes mellitus: In summary, our study demonstrated that activating the HIF-1α pathway in osteoblasts can promote glucose metabolism under diabetic conditions via RegIIIγ and suggested that the osteoblastic HIF-1α-RegIIIγ pathway is a potential target for treating T1DM (Fig. 7).